Loading clinical trials...
Loading clinical trials...
The goal of this observational study is to evaluate the functionality and usability of Indivi mobile application-based cognitive activities in people with mild cognitive impairment/mild Alzheimer's di...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Indivi AG
NCT07101380 · Mild Cognitive Impairment (MCI)
NCT06669546 · Cognitive Decline, Alzheimer Disease, and more
NCT06780917 · Mild Cognitive Impairment (MCI), Major Depressive Disorder, Remitted, and more
NCT07449117 · Mild Cognitive Impairment (MCI) Amnestic, Lewy Body Disease With Mild Cognitive Impairment, and more
NCT07420426 · Mild Cognitive Impairment (MCI)
Boston University School of Medicine
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions